MAPKAPK5 and rheumatoid arthritis: Additionally, XFC-containing serum can effectively promote TNF-α-induced apoptosis of RA-FLS, inhibit abnormal proliferation of RA-FLS, and alleviate RA conditions by regulating lncRNA MAPKAPK5-AS1 (25).